Transdermal Skin Patch Industry Research Report 2025

Summary

According to APO Research, the global Transdermal Skin Patch market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Transdermal Skin Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Transdermal Skin Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Transdermal Skin Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Transdermal Skin Patch include Actavis, Changzhou Siyao, Henan Lingrui Pharmaceutical, Hisamitsu Pharmaceutical, Luye Pharma Group Ltd., Mundipharma, Purdue Pharma L.P., Rfl Pharmaceutical and Teikoku Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Transdermal Skin Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Skin Patch.

The report will help the Transdermal Skin Patch manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Transdermal Skin Patch market size, estimations, and forecasts are provided in terms of sales volume (W Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Transdermal Skin Patch market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Transdermal Skin Patch Segment by Company

Actavis
Changzhou Siyao
Henan Lingrui Pharmaceutical
Hisamitsu Pharmaceutical
Luye Pharma Group Ltd.
Mundipharma
Purdue Pharma L.P.
Rfl Pharmaceutical
Teikoku Pharma
Mylan
Novartis
Johnson & Johnson
Teva Pharmaceutical Industries Ltd.
Transdermal Skin Patch Segment by Type

Buprenorphine Transdermal Skin Patch
Fentanyl Transdermal Skin Patch
Clonidine Transdermal Skin Patch
Nicotine Transdermal Skin Patch
Transdermal Skin Patch Segment by Application

Relieve Severe Pain
Stop Smoking Cigarettes
Treat an Overactive Bladder
Others
Transdermal Skin Patch Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Colombia
Middle East Middle East & Africa
Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Skin Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transdermal Skin Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Skin Patch.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Transdermal Skin Patch manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Transdermal Skin Patch by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Transdermal Skin Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Transdermal Skin Patch Market Size (2020-2031)
2.2.2 Global Transdermal Skin Patch Sales (2020-2031)
2.2.3 Global Transdermal Skin Patch Market Average Price (2020-2031)
2.3 Transdermal Skin Patch by Type
2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
2.3.2 Buprenorphine Transdermal Skin Patch
2.3.3 Fentanyl Transdermal Skin Patch
2.3.4 Clonidine Transdermal Skin Patch
2.3.5 Nicotine Transdermal Skin Patch
2.4 Transdermal Skin Patch by Application
2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.4.2 Relieve Severe Pain
2.4.3 Stop Smoking Cigarettes
2.4.4 Treat an Overactive Bladder
2.4.5 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Transdermal Skin Patch Market Competitive Situation by Manufacturers (2020 Versus 2024)
3.2 Global Transdermal Skin Patch Sales (W Units) of Manufacturers (2020-2025)
3.3 Global Transdermal Skin Patch Revenue of Manufacturers (2020-2025)
3.4 Global Transdermal Skin Patch Average Price by Manufacturers (2020-2025)
3.5 Global Transdermal Skin Patch Industry Ranking, 2023 VS 2024 VS 2025
3.6 Global Manufacturers of Transdermal Skin Patch, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Transdermal Skin Patch, Product Type & Application
3.8 Global Manufacturers of Transdermal Skin Patch, Established Date
3.9 Global Transdermal Skin Patch Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Actavis
4.1.1 Actavis Company Information
4.1.2 Actavis Business Overview
4.1.3 Actavis Transdermal Skin Patch Sales, Revenue and Gross Margin (2020-2025)
4.1.4 Actavis Transdermal Skin Patch Product Portfolio
4.1.5 Actavis Recent Developments
4.2 Changzhou Siyao
4.2.1 Changzhou Siyao Company Information
4.2.2 Changzhou Siyao Business Overview
4.2.3 Changzhou Siyao Transdermal Skin Patch Sales, Revenue and Gross Margin (2020-2025)
4.2.4 Changzhou Siyao Transdermal Skin Patch Product Portfolio
4.2.5 Changzhou Siyao Recent Developments
4.3 Henan Lingrui Pharmaceutical
4.3.1 Henan Lingrui Pharmaceutical Company Information
4.3.2 Henan Lingrui Pharmaceutical Business Overview
4.3.3 Henan Lingrui Pharmaceutical Transdermal Skin Patch Sales, Revenue and Gross Margin (2020-2025)
4.3.4 Henan Lingrui Pharmaceutical Transdermal Skin Patch Product Portfolio
4.3.5 Henan Lingrui Pharmaceutical Recent Developments
4.4 Hisamitsu Pharmaceutical
4.4.1 Hisamitsu Pharmaceutical Company Information
4.4.2 Hisamitsu Pharmaceutical Business Overview
4.4.3 Hisamitsu Pharmaceutical Transdermal Skin Patch Sales, Revenue and Gross Margin (2020-2025)
4.4.4 Hisamitsu Pharmaceutical Transdermal Skin Patch Product Portfolio
4.4.5 Hisamitsu Pharmaceutical Recent Developments
4.5 Luye Pharma Group Ltd.
4.5.1 Luye Pharma Group Ltd. Company Information
4.5.2 Luye Pharma Group Ltd. Business Overview
4.5.3 Luye Pharma Group Ltd. Transdermal Skin Patch Sales, Revenue and Gross Margin (2020-2025)
4.5.4 Luye Pharma Group Ltd. Transdermal Skin Patch Product Portfolio
4.5.5 Luye Pharma Group Ltd. Recent Developments
4.6 Mundipharma
4.6.1 Mundipharma Company Information
4.6.2 Mundipharma Business Overview
4.6.3 Mundipharma Transdermal Skin Patch Sales, Revenue and Gross Margin (2020-2025)
4.6.4 Mundipharma Transdermal Skin Patch Product Portfolio
4.6.5 Mundipharma Recent Developments
4.7 Purdue Pharma L.P.
4.7.1 Purdue Pharma L.P. Company Information
4.7.2 Purdue Pharma L.P. Business Overview
4.7.3 Purdue Pharma L.P. Transdermal Skin Patch Sales, Revenue and Gross Margin (2020-2025)
4.7.4 Purdue Pharma L.P. Transdermal Skin Patch Product Portfolio
4.7.5 Purdue Pharma L.P. Recent Developments
4.8 Rfl Pharmaceutical
4.8.1 Rfl Pharmaceutical Company Information
4.8.2 Rfl Pharmaceutical Business Overview
4.8.3 Rfl Pharmaceutical Transdermal Skin Patch Sales, Revenue and Gross Margin (2020-2025)
4.8.4 Rfl Pharmaceutical Transdermal Skin Patch Product Portfolio
4.8.5 Rfl Pharmaceutical Recent Developments
4.9 Teikoku Pharma
4.9.1 Teikoku Pharma Company Information
4.9.2 Teikoku Pharma Business Overview
4.9.3 Teikoku Pharma Transdermal Skin Patch Sales, Revenue and Gross Margin (2020-2025)
4.9.4 Teikoku Pharma Transdermal Skin Patch Product Portfolio
4.9.5 Teikoku Pharma Recent Developments
4.10 Mylan
4.10.1 Mylan Company Information
4.10.2 Mylan Business Overview
4.10.3 Mylan Transdermal Skin Patch Sales, Revenue and Gross Margin (2020-2025)
4.10.4 Mylan Transdermal Skin Patch Product Portfolio
4.10.5 Mylan Recent Developments
4.11 Novartis
4.11.1 Novartis Company Information
4.11.2 Novartis Business Overview
4.11.3 Novartis Transdermal Skin Patch Sales, Revenue and Gross Margin (2020-2025)
4.11.4 Novartis Transdermal Skin Patch Product Portfolio
4.11.5 Novartis Recent Developments
4.12 Johnson & Johnson
4.12.1 Johnson & Johnson Company Information
4.12.2 Johnson & Johnson Business Overview
4.12.3 Johnson & Johnson Transdermal Skin Patch Sales, Revenue and Gross Margin (2020-2025)
4.12.4 Johnson & Johnson Transdermal Skin Patch Product Portfolio
4.12.5 Johnson & Johnson Recent Developments
4.13 Teva Pharmaceutical Industries Ltd.
4.13.1 Teva Pharmaceutical Industries Ltd. Company Information
4.13.2 Teva Pharmaceutical Industries Ltd. Business Overview
4.13.3 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Sales, Revenue and Gross Margin (2020-2025)
4.13.4 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Product Portfolio
4.13.5 Teva Pharmaceutical Industries Ltd. Recent Developments
5 Global Transdermal Skin Patch Market Scenario by Region
5.1 Global Transdermal Skin Patch Market Size by Region: 2020 VS 2024 VS 2031
5.2 Global Transdermal Skin Patch Sales by Region: 2020-2031
5.2.1 Global Transdermal Skin Patch Sales by Region: 2020-2025
5.2.2 Global Transdermal Skin Patch Sales by Region: 2026-2031
5.3 Global Transdermal Skin Patch Revenue by Region: 2020-2031
5.3.1 Global Transdermal Skin Patch Revenue by Region: 2020-2025
5.3.2 Global Transdermal Skin Patch Revenue by Region: 2026-2031
5.4 North America Transdermal Skin Patch Market Facts & Figures by Country
5.4.1 North America Transdermal Skin Patch Market Size by Country: 2020 VS 2024 VS 2031
5.4.2 North America Transdermal Skin Patch Sales by Country (2020-2031)
5.4.3 North America Transdermal Skin Patch Revenue by Country (2020-2031)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Transdermal Skin Patch Market Facts & Figures by Country
5.5.1 Europe Transdermal Skin Patch Market Size by Country: 2020 VS 2024 VS 2031
5.5.2 Europe Transdermal Skin Patch Sales by Country (2020-2031)
5.5.3 Europe Transdermal Skin Patch Revenue by Country (2020-2031)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Transdermal Skin Patch Market Facts & Figures by Country
5.6.1 Asia Pacific Transdermal Skin Patch Market Size by Country: 2020 VS 2024 VS 2031
5.6.2 Asia Pacific Transdermal Skin Patch Sales by Country (2020-2031)
5.6.3 Asia Pacific Transdermal Skin Patch Revenue by Country (2020-2031)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Transdermal Skin Patch Market Facts & Figures by Country
5.7.1 South America Transdermal Skin Patch Market Size by Country: 2020 VS 2024 VS 2031
5.7.2 South America Transdermal Skin Patch Sales by Country (2020-2031)
5.7.3 South America Transdermal Skin Patch Revenue by Country (2020-2031)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.7.7 Colombia
5.8 Middle East and Africa Transdermal Skin Patch Market Facts & Figures by Country
5.8.1 Middle East and Africa Transdermal Skin Patch Market Size by Country: 2020 VS 2024 VS 2031
5.8.2 Middle East and Africa Transdermal Skin Patch Sales by Country (2020-2031)
5.8.3 Middle East and Africa Transdermal Skin Patch Revenue by Country (2020-2031)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Transdermal Skin Patch Sales by Type (2020-2031)
6.1.1 Global Transdermal Skin Patch Sales by Type (2020-2031) & (W Units)
6.1.2 Global Transdermal Skin Patch Sales Market Share by Type (2020-2031)
6.2 Global Transdermal Skin Patch Revenue by Type (2020-2031)
6.2.1 Global Transdermal Skin Patch Sales by Type (2020-2031) & (US$ Million)
6.2.2 Global Transdermal Skin Patch Revenue Market Share by Type (2020-2031)
6.3 Global Transdermal Skin Patch Price by Type (2020-2031)
7 Segment by Application
7.1 Global Transdermal Skin Patch Sales by Application (2020-2031)
7.1.1 Global Transdermal Skin Patch Sales by Application (2020-2031) & (W Units)
7.1.2 Global Transdermal Skin Patch Sales Market Share by Application (2020-2031)
7.2 Global Transdermal Skin Patch Revenue by Application (2020-2031)
7.2.1 Global Transdermal Skin Patch Sales by Application (2020-2031) & (US$ Million)
7.2.2 Global Transdermal Skin Patch Revenue Market Share by Application (2020-2031)
7.3 Global Transdermal Skin Patch Price by Application (2020-2031)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Transdermal Skin Patch Value Chain Analysis
8.1.1 Transdermal Skin Patch Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Transdermal Skin Patch Production Mode & Process
8.2 Transdermal Skin Patch Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Transdermal Skin Patch Distributors
8.2.3 Transdermal Skin Patch Customers
9 Global Transdermal Skin Patch Analyzing Market Dynamics
9.1 Transdermal Skin Patch Industry Trends
9.2 Transdermal Skin Patch Industry Drivers
9.3 Transdermal Skin Patch Industry Opportunities and Challenges
9.4 Transdermal Skin Patch Industry Restraints
10 Report Conclusion
11 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings